Skip to main content

World Health Day 2024: QNET Highlights Vital Role Of Supplements In Promoting Holistic Wellnes

As the world marks World Health Day 2024, QNET, a global leader in e-commerce-based direct selling, has taken significant steps to promote holistic wellness by introducing a range of innovative health supplements. With a steadfast commitment to enhancing lives globally, QNET works with leading health experts and utilizes cutting-edge research to unveil supplements designed to address diverse health needs and promote total well-being.


In today’s world, good health and well-being are of prime importance, and the significance of dietary supplements in achieving total wellness cannot be overstated. World Health Organization statistics show that the impact of low nutrition-related diseases accounts for 73% of all deaths and 60% of the global disease burden. As individuals are increasingly seeking comprehensive solutions to bridge nutritional gaps and improve their general health, QNET emerges as a leading advocate for health equity with its range of high-quality health supplements. By focusing on the transformative role of supplements in promoting well-being, QNET sets a new standard in the goal of holistic wellness.


“At QNET, we recognize the pivotal role of supplements in bridging nutritional gaps and promoting holistic wellness,” stated Biram Fall, Regional General Manager, QNET Sub-Saharan Africa. “Our range of high-quality supplements is meticulously formulated to cater to the diverse needs of individuals seeking to optimize their health and well-being from strengthening immune systems to managing weights effectively. Some of our products include KENTA, BELITE, QALIVE and EDG3 Plus. By harnessing the power of nature and science, we aim to redefine the standards of health supplementation and empower people to lead healthier, more fulfilling lives.”

One of QNET’s notable products, the EDG3 Plus immune-boosting supplement, not only safeguards and restores organ health but also saves blood vessels and heart health. It showcases the company’s commitment to offering accessible and affordable solutions for acquiring important immune-boosting vitamins and amino acids. Particularly crucial in regions where access to fresh produce may be limited or expensive, EDG3 Plus represents a gateway to improved health and well-being for individuals seeking to fortify their immune systems and overall health.

“As we commemorate World Health Day, QNET reaffirms its unwavering commitment to empowering individuals to prioritize their health and well-being,” added Hakeem Ajisafe, Chief Executive Officer, Transblue Limited. “We believe that by offering innovative supplements and fostering a culture of wellness, we can inspire positive transformations in the lives of people worldwide. We urge people worldwide to prioritize their health and embrace the transformative power of supplements in achieving comprehensive well-being.

QNET’s commitment to global wellness goes beyond product innovation. The company actively engages in efforts to raise awareness about the importance of preventive healthcare and ease access to quality supplements worldwide. Through strategic collaborations with healthcare professionals and advocacy groups, QNET aims to create a supportive ecosystem where individuals can make informed choices about their health and wellness journey.

Comments

Popular posts from this blog

Cutting calories may reduce cellular ageing and increase lifetime.

State College, Pennsylvania — Penn State researchers are presenting fresh persuasive data linking diets to ageing. Their study focused on telomeres, the genetic "end caps" that protect our chromosomes, and how calorie restriction impacts them. The scientists studied data from a two-year trial of caloric restriction in humans and published their findings in the journal Ageing Cell. They discovered that those who restricted their calories lost telomeres at different rates than the control group. Despite this, both groups concluded the research with roughly identical telomere lengths. Previous research found that reducing calories by 20 to 60 percent resulted in prolonged life for a variety of species. When a person's cells split, some telomeres are lost as chromosomes are copied to a new cell. The cell's telomeres are then shortened in total. The telomere cap eventually disappears as cells divide. The genetic information on the chromosome becomes more vulnerable to de...

DUI without alcohol? A rare syndrome in the intestines may be the culprit.

  Imagine you are a police officer. You see a car swerving all over the road. You pull over the driver, and they are plainly inebriated. They insist, with slurred speech, that they haven't consumed any alcohol all day. Do you believe them? In 2024, a Belgian man was acquitted after being arrested three times for DUI in four years. Though his position at a brewery raised suspicions, he asserted that he had not been drinking. Three doctors confirmed that he had auto-brewery syndrome and was ignorant. People with this illness have microorganisms in their intestines that produce abnormally high levels of alcohol when they break down sugars and carbs. Though it is an uncommon condition, a lady was acquitted of a DUI conviction in 2016 after being diagnosed with the same syndrome. Her blood alcohol level was four times the legal limit. I am a microbiologist who is fascinated by how the gut microbiome influences human health. As the author of the book "Pleased to Meet Me: Genes, G...

A study reveals serious side effects from common dementia medications.

Several antipsychotic medications used to treat dementia patients have been linked to dangerous side effects such as heart failure, according to a study released Thursday. A study published in the British Medical Journal (BMJ) found that using antipsychotics in persons with dementia can lead to major adverse outcomes such as stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney injury. Scientists discovered that the greatest hazards arise when therapy begins, "underscoring the need for increased caution in the early stages of treatment". Risperidone, quetiapine, haloperidol, and olanzapine are common antipsychotic medications used to treat psychotic illnesses such as schizophrenia. They are also used to treat depression that has proven resistant to other drugs, as well as those suffering from dementia, such as Alzheimer's disease. Antipsychotics are not designed to heal these conditions, but rather to alleviate certain symptoms such ...